{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:01:54Z","timestamp":1787317314030,"version":"build-2736575974"},"reference-count":286,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11010-025-05258-3","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T06:12:03Z","timestamp":1744006323000},"page":"4587-4612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases"],"prefix":"10.1007","volume":"480","author":[{"given":"Biswajit Kumar","family":"Utpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Al Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrukh","family":"Zehravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk Hussein","family":"Sweilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uppuluri Varuna Naga Venkata","family":"Arjun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Bala","family":"Madhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeetendra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Yaidikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Tummala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Suseela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiladevi","family":"Durairaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konatham Teja Kumar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Audah Fahaid","family":"Al Fahaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Saeed","family":"Almahjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"5258_CR1","first-page":"22","volume":"5","author":"R Kromer","year":"2014","unstructured":"Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC (2014) Detection of retinal nerve fiber layer defects in Alzheimer\u2019s disease using SD-OCT. Front Psych 5:22","journal-title":"Front Psych"},{"key":"5258_CR2","first-page":"1575","volume":"12","author":"H Sharma","year":"2023","unstructured":"Sharma H, Chandra P, Verma A, Pandey SN, Kumar P, Sigh A (2023) Therapeutic approaches of nutraceuticals in the prevention of neurological disorders. Eur Chem Bull 12:1575\u20131596","journal-title":"Eur Chem Bull"},{"key":"5258_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, Von Strauss E (2009) Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111\u2013128","journal-title":"Dialogues Clin Neurosci"},{"key":"5258_CR4","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.3390\/ijms24054399","volume":"24","author":"R Vrabec","year":"2023","unstructured":"Vrabec R, Blunden G, Cahl\u00edkov\u00e1 L (2023) Natural alkaloids as multi-target compounds towards factors implicated in Alzheimer\u2019s disease. Int J Mol Sci 24:4399","journal-title":"Int J Mol Sci"},{"key":"5258_CR5","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","volume":"93","author":"M Simunkova","year":"2019","unstructured":"Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M, Valko M (2019) Management of oxidative stress and other pathologies in Alzheimer\u2019s disease. Arch Toxicol 93:2491\u20132513","journal-title":"Arch Toxicol"},{"key":"5258_CR6","first-page":"103","volume-title":"Drug delivery strategies in neurological disorders: challenges and opportunities","author":"KS Samim","year":"2024","unstructured":"Samim KS, Naren P, Pinjala P, Uppala S, Singh SB, Khatri DK (2024) Pathophysiology and management approaches for parkinson\u2019s disease. Drug delivery strategies in neurological disorders: challenges and opportunities. Springer, Cham, pp 103\u2013153"},{"key":"5258_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111826","volume":"213","author":"SN Uppala","year":"2023","unstructured":"Uppala SN, Tryphena KP, Naren P, Srivastava S, Singh SB, Khatri DK (2023) Involvement of miRNA on epigenetics landscape of Parkinson\u2019s disease: from pathogenesis to therapeutics. Mech Ageing Dev 213:111826","journal-title":"Mech Ageing Dev"},{"key":"5258_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan S, Tryphena KP, Khan S, Vora L, Srivastava S, Singh SB, Khatri DK (2023) Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Res Rev 87:101915","journal-title":"Ageing Res Rev"},{"key":"5258_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"SS Khan","year":"2023","unstructured":"Khan SS, Janrao S, Srivastava S, Singh SB, Vora L, Khatri DK (2023) GSK-3\u03b2: An exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochem Pharmacol 210:115496","journal-title":"Biochem Pharmacol"},{"key":"5258_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13721-024-00445-6","volume":"13","author":"G Singh","year":"2024","unstructured":"Singh G, Khatri DK (2024) MicroRNA-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson\u2019s disease: a bioinformatics approach. Netw Model Anal Health Inform Bioinform 13:7","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"5258_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-444-64183-0.00008-7","volume":"61","author":"JA Lima","year":"2019","unstructured":"Lima JA, Hamerski L (2019) Alkaloids as potential multi-target drugs to treat Alzheimer\u2019s disease. Stud Nat Prod Chem 61:301\u2013334","journal-title":"Stud Nat Prod Chem"},{"key":"5258_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mtchem.2018.05.001","volume":"9","author":"B Debnath","year":"2018","unstructured":"Debnath B, Singh WS, Das M, Goswami S, Singh MK, Maiti D, Manna K (2018) Role of plant alkaloids on human health: a review of biological activities. Mater Today Chem 9:56\u201372","journal-title":"Mater Today Chem"},{"key":"5258_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fphar.2019.00351","volume":"10","author":"J Peng","year":"2019","unstructured":"Peng J, Zheng T-T, Li X, Liang Y, Wang L-J, Huang Y-C, Xiao H-T (2019) Plant-derived alkaloids: the promising disease-modifying agents for inflammatory bowel disease. Front Pharmacol 10:351","journal-title":"Front Pharmacol"},{"key":"5258_CR14","volume":"6","author":"S Sirin","year":"2023","unstructured":"Sirin S, Dolanbay SN, Aslim B (2023) Role of plant derived alkaloids as antioxidant agents for neurodegenerative diseases. Health Sci Rev 6:100071","journal-title":"Health Sci Rev"},{"key":"5258_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.13005\/ojc\/340270","volume":"34","author":"A Dalimunthe","year":"2018","unstructured":"Dalimunthe A, Hasibuan PAZ, Silalahi J, Sinaga SF, Satria D (2018) Antioxidant activity of alkaloid compounds from Litsea cubeba Lour. Orient J Chem 34:1149","journal-title":"Orient J Chem"},{"key":"5258_CR16","doi-asserted-by":"publisher","first-page":"8401","DOI":"10.4081\/ni.2020.8401","volume":"12","author":"JL Orozco","year":"2020","unstructured":"Orozco JL, Valderrama-Chaparro JA, Pinilla-Monsalve GD, Molina-Echeverry MI, P\u00e9rez Casta\u00f1o AM, Ariza-Ara\u00fajo Y, Prada SI, Takeuchi Y (2020) Parkinson\u2019s disease prevalence, age distribution and staging in Colombia. Neurol Int 12:8401","journal-title":"Neurol Int"},{"key":"5258_CR17","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.3390\/molecules26133990","volume":"26","author":"A Ibrakaw","year":"2021","unstructured":"Ibrakaw A, Omoruyi S, Ekpo O (2021) Neuroprotective activities of Crossyne flava bulbs and amaryllidaceae alkaloids: implications for Parkinson\u2019s disease. Molecules 26:3990","journal-title":"Molecules"},{"key":"5258_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.970714","volume":"13","author":"P Kempster","year":"2022","unstructured":"Kempster P, Ma A (2022) Parkinson\u2019s disease, dopaminergic drugs and the plant world. Front Pharmacol 13:970714","journal-title":"Front Pharmacol"},{"key":"5258_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10072-010-0245-1","volume":"31","author":"S Surendran","year":"2010","unstructured":"Surendran S, Rajasankar S (2010) Parkinson\u2019s disease: oxidative stress and therapeutic approaches. Neurol Sci 31:531\u2013540","journal-title":"Neurol Sci"},{"key":"5258_CR20","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1021\/acs.jmedchem.7b01922","volume":"61","author":"SS Bharate","year":"2018","unstructured":"Bharate SS, Mignani S, Vishwakarma RA (2018) Why are the majority of active compounds in the CNS domain natural products? A critical analysis. J Med Chem 61:10345\u201310374","journal-title":"J Med Chem"},{"key":"5258_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","volume":"89","author":"YP Ng","year":"2015","unstructured":"Ng YP, Or TCT, Ip NY (2015) Plant alkaloids as drug leads for Alzheimer\u2019s disease. Neurochem Int 89:260\u2013270","journal-title":"Neurochem Int"},{"key":"5258_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111690","volume":"140","author":"SN Dolanbay","year":"2021","unstructured":"Dolanbay SN, Kocanci FG, Aslim B (2021) Neuroprotective effects of allocryptopine-rich alkaloid extracts against oxidative stress-induced neuronal damage. Biomed Pharmacother 140:111690","journal-title":"Biomed Pharmacother"},{"key":"5258_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112540","volume":"251","author":"S Liang","year":"2020","unstructured":"Liang S, Zheng Y, Lei L, Deng X, Ai J, Li Y, Zhang T, Mei Z, Ren Y (2020) Corydalis edulis total alkaloids (CETA) ameliorates cognitive dysfunction in rat model of Alzheimer disease through regulation of the antioxidant stress and MAP2\/NF-\u03baB. J Ethnopharmacol 251:112540","journal-title":"J Ethnopharmacol"},{"key":"5258_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.freeradbiomed.2010.07.017","volume":"49","author":"Y-T Shih","year":"2010","unstructured":"Shih Y-T, Chen PS, Wu C-H, Tseng Y-T, Wu Y-C, Lo Y-C (2010) Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement of oxidative stress and suppression of the antioxidant protective system. Free Radical Biol Med 49:1471\u20131479","journal-title":"Free Radical Biol Med"},{"key":"5258_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/cn500258c","volume":"6","author":"M Leir\u00f3s","year":"2015","unstructured":"Leir\u00f3s M, Alonso E, Rateb M, Houssen W, Ebel R, Jaspars M, Alfonso A, Botana L (2015) Bromoalkaloids protect primary cortical neurons from induced oxidative stress. ACS Chem Neurosci 6:331\u2013338","journal-title":"ACS Chem Neurosci"},{"key":"5258_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","volume":"184","author":"JR Cannon","year":"2010","unstructured":"Cannon JR, Greenamyre JT (2010) Neurotoxic in vivo models of Parkinson\u2019s disease: recent advances. Prog Brain Res 184:17\u201333","journal-title":"Prog Brain Res"},{"key":"5258_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10571-004-1375-x","volume":"25","author":"R Haseloff","year":"2005","unstructured":"Haseloff R, Blasig I, Bauer H-C, Bauer H (2005) In search of the astrocytic factor (s) modulating blood\u2013brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol 25:25\u201339","journal-title":"Cell Mol Neurobiol"},{"key":"5258_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57:178\u2013201","journal-title":"Neuron"},{"key":"5258_CR29","first-page":"7","volume":"61","author":"P Chandra","year":"2024","unstructured":"Chandra P, Sharma H (2024) Phosphodiesterase inhibitors for treatment of Alzheimer\u2019s disease. Indian Drugs 61:7\u201322","journal-title":"Indian Drugs"},{"key":"5258_CR30","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s11064-007-9342-9","volume":"32","author":"J Lok","year":"2007","unstructured":"Lok J, Gupta P, Guo S, Kim WJ, Whalen MJ, van Leyen K, Lo EH (2007) Cell\u2013cell signaling in the neurovascular unit. Neurochem Res 32:2032\u20132045","journal-title":"Neurochem Res"},{"key":"5258_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/brain\/awq377","volume":"134","author":"TR Melzer","year":"2011","unstructured":"Melzer TR, Watts R, MacAskill MR, Pearson JF, R\u00fceger S, Pitcher TL, Livingston L, Graham C, Keenan R, Shankaranarayanan A (2011) Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson\u2019s disease. Brain 134:845\u2013855","journal-title":"Brain"},{"key":"5258_CR32","doi-asserted-by":"publisher","first-page":"E290424229510","DOI":"10.2174\/0115734072292339240416095600","volume":"21","author":"P Chandra","year":"2025","unstructured":"Chandra P, Ali Z, Fatima N, Sharma H, Sachan N, Sharma KK, Verma A (2025) Shankhpushpi (Convolvulus pluricaulis): exploring its cognitive enhancing mechanisms and therapeutic potential in neurodegenerative disorders. Curr Bioact Compd 21:E290424229510","journal-title":"Curr Bioact Compd"},{"key":"5258_CR33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ars.2011.4082","volume":"16","author":"R Von Bernhardi","year":"2012","unstructured":"Von Bernhardi R, Eugen\u00edn J (2012) Alzheimer\u2019s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid Redox Signal 16:974\u20131031","journal-title":"Antioxid Redox Signal"},{"key":"5258_CR34","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1089\/ars.2010.3547","volume":"15","author":"V Chiurchiu","year":"2011","unstructured":"Chiurchiu V, Maccarrone M (2011) Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15:2605\u20132641","journal-title":"Antioxid Redox Signal"},{"key":"5258_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bcp.2012.05.005","volume":"84","author":"I-T Lee","year":"2012","unstructured":"Lee I-T, Yang C-M (2012) Role of NADPH oxidase\/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochem Pharmacol 84:581\u2013590","journal-title":"Biochem Pharmacol"},{"key":"5258_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"B Uttara","year":"2009","unstructured":"Uttara B, Singh AV, Zamboni P, Mahajan R (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65\u201374","journal-title":"Curr Neuropharmacol"},{"key":"5258_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/467180","author":"A Melo","year":"2011","unstructured":"Melo A, Monteiro L, Lima RM, de Oliveira DM, de Cerqueira MD, El-Bach\u00e1 RS (2011) Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxidative Med Cell Longevity. https:\/\/doi.org\/10.1155\/2011\/467180","journal-title":"Oxidative Med Cell Longevity"},{"key":"5258_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.neurol.2014.03.005","volume":"170","author":"V Procaccio","year":"2014","unstructured":"Procaccio V, Bris C, De La Barca JC, Oca F, Chevrollier A, Amati-Bonneau P, Bonneau D, Reynier P (2014) Perspectives of drug-based neuroprotection targeting mitochondria. Revue Neurologique 170:390\u2013400","journal-title":"Revue Neurologique"},{"key":"5258_CR39","first-page":"45","volume":"39","author":"Z Huang","year":"2021","unstructured":"Huang Z, Zhou R (2021) Neuroinflammation & neurodegenerative diseases. Sci Technol Rev 39:45\u201355","journal-title":"Sci Technol Rev"},{"key":"5258_CR40","doi-asserted-by":"publisher","DOI":"10.2174\/0118715273330972241009092828","author":"A Al Noman","year":"2024","unstructured":"Al Noman A, Afrosa H, Lihu IK, Sarkar O, Nabin NR, Datta M, Pathak R, Sharma H (2024) Vitamin D and neurological health: unraveling risk factors, disease progression, and treatment potential. CNS Neurol Disord. https:\/\/doi.org\/10.2174\/0118715273330972241009092828","journal-title":"CNS Neurol Disord"},{"key":"5258_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/JIR.S86958","volume":"9","author":"MR Bronzuoli","year":"2016","unstructured":"Bronzuoli MR, Iacomino A, Steardo L, Scuderi C (2016) Targeting neuroinflammation in Alzheimer\u2019s disease. J Inflamm Res 9:199\u2013208","journal-title":"J Inflamm Res"},{"key":"5258_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-981-99-8373-5_11","volume-title":"Exosomes based drug delivery strategies for brain disorders","author":"P Kumar","year":"2024","unstructured":"Kumar P, Sharma H, Singh A, Pandey SN, Chandra P (2024) Correlation between exosomes and neuro-inflammation in various brain disorders. Exosomes based drug delivery strategies for brain disorders. Springer, Cham, pp 273\u2013302"},{"key":"5258_CR43","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3390\/ijms23084148","volume":"23","author":"T-W Liu","year":"2022","unstructured":"Liu T-W, Chen C-M, Chang K-H (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 23:4148","journal-title":"Int J Mol Sci"},{"key":"5258_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jfmk3010013","volume":"3","author":"G Al-Badri","year":"2018","unstructured":"Al-Badri G, Castorina A (2018) Insights into the role of neuroinflammation in the pathogenesis of multiple sclerosis. J Funct Morphol Kinesiol 3:13","journal-title":"J Funct Morphol Kinesiol"},{"key":"5258_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"K Dasuri","year":"2013","unstructured":"Dasuri K, Zhang L, Keller JN (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radical Biol Med 62:170\u2013185","journal-title":"Free Radical Biol Med"},{"key":"5258_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197152","author":"S Gandhi","year":"2012","unstructured":"Gandhi S, Abramov AY (2012) Mechanism of oxidative stress in neurodegeneration. Oxidative Med Cell Longevity. https:\/\/doi.org\/10.3390\/ijms21197152","journal-title":"Oxidative Med Cell Longevity"},{"key":"5258_CR47","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.3390\/ijms21197152","volume":"21","author":"KH Lee","year":"2020","unstructured":"Lee KH, Cha M, Lee BH (2020) Neuroprotective effect of antioxidants in the brain. Int J Mol Sci 21:7152","journal-title":"Int J Mol Sci"},{"key":"5258_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","volume":"1842","author":"L Gan","year":"2014","unstructured":"Gan L, Johnson JA (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta 1842:1208\u20131218","journal-title":"Biochim Biophys Acta"},{"key":"5258_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2008.06.045","volume":"591","author":"X Xiao","year":"2008","unstructured":"Xiao X, Liu J, Hu J, Zhu X, Yang H, Wang C, Zhang Y (2008) Protective effects of protopine on hydrogen peroxide-induced oxidative injury of PC12 cells via Ca2+ antagonism and antioxidant mechanisms. Eur J Pharmacol 591:21\u201327","journal-title":"Eur J Pharmacol"},{"key":"5258_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt MF, Gan ZY, Komander D, Dewson G (2021) Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ 28:570\u2013590","journal-title":"Cell Death Differ"},{"key":"5258_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205\u2013214","journal-title":"Nat Rev Drug Discov"},{"key":"5258_CR52","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","volume":"53","author":"E Niedzielska","year":"2016","unstructured":"Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M (2016) Oxidative stress in neurodegenerative diseases. Mol Neurobiol 53:4094\u20134125","journal-title":"Mol Neurobiol"},{"key":"5258_CR53","first-page":"47","volume":"30","author":"I Ciancarelli","year":"2015","unstructured":"Ciancarelli I, De Amicis D, Di Massimo C, Sandrini G, Pistarini C, Carolei A, Ciancarelli MGT (2015) Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington\u2019s disease. Funct Neurol 30:47","journal-title":"Funct Neurol"},{"key":"5258_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","volume":"49","author":"Y Wu","year":"2019","unstructured":"Wu Y, Chen M, Jiang J (2019) Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion 49:35\u201345","journal-title":"Mitochondrion"},{"key":"5258_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342:619\u2013630","journal-title":"J Pharmacol Exp Ther"},{"key":"5258_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/175062","volume":"2014","author":"J Hroudov\u00e1","year":"2014","unstructured":"Hroudov\u00e1 J, Singh N, Fi\u0161ar Z (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer\u2019s disease. Biomed Res Int 2014:175062","journal-title":"Biomed Res Int"},{"key":"5258_CR57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xu E, Musich PR, Lin F (2019) Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther 25:816\u2013824","journal-title":"CNS Neurosci Ther"},{"key":"5258_CR58","first-page":"1","volume":"2","author":"M Takalo","year":"2013","unstructured":"Takalo M, Salminen A, Soininen H, Hiltunen M, Haapasalo A (2013) Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am J Neurodegener Dis 2:1","journal-title":"Am J Neurodegener Dis"},{"key":"5258_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/9789815040913122010005","volume-title":"Neurodegenerative diseases: multifactorial degenerative processes, biomarkers and therapeutic approaches","author":"R Chaudhary","year":"2022","unstructured":"Chaudhary R, Rehman M, Agarwal V, Kaushik AS, Mishra V (2022) Protein aggregation in neurodegenerative diseases. Neurodegenerative diseases: multifactorial degenerative processes, biomarkers and therapeutic approaches. Bentham Science Publishers, Sharjah, pp 26\u201358"},{"key":"5258_CR60","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","volume":"88","author":"J Vaquer-Alicea","year":"2019","unstructured":"Vaquer-Alicea J, Diamond MI (2019) Propagation of protein aggregation in neurodegenerative diseases. Annu Rev Biochem 88:785\u2013810","journal-title":"Annu Rev Biochem"},{"key":"5258_CR61","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","volume":"124","author":"V Kumar","year":"2016","unstructured":"Kumar V, Sami N, Kashav T, Islam A, Ahmad F, Hassan MI (2016) Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur J Med Chem 124:1105\u20131120","journal-title":"Eur J Med Chem"},{"key":"5258_CR62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuint.2017.08.004","volume":"117","author":"C Rodolfo","year":"2018","unstructured":"Rodolfo C, Campello S, Cecconi F (2018) Mitophagy in neurodegenerative diseases. Neurochem Int 117:156\u2013166","journal-title":"Neurochem Int"},{"key":"5258_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnmol.2017.00064","volume":"10","author":"M Martinez-Vicente","year":"2017","unstructured":"Martinez-Vicente M (2017) Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci 10:64","journal-title":"Front Mol Neurosci"},{"key":"5258_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10863-017-9727-7","volume":"49","author":"H Liu","year":"2017","unstructured":"Liu H, Dai C, Fan Y, Guo B, Ren K, Sun T, Wang W (2017) From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases. J Bioenerg Biomembr 49:413\u2013422","journal-title":"J Bioenerg Biomembr"},{"key":"5258_CR65","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/cns.13140","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu N, Lu B (2019) Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci Ther 25:859\u2013875","journal-title":"CNS Neurosci Ther"},{"key":"5258_CR66","doi-asserted-by":"publisher","first-page":"1100133","DOI":"10.3389\/fnagi.2022.1100133","volume":"14","author":"M Lin","year":"2023","unstructured":"Lin M, Yu H, Xie Q, Xu Z, Shang P (2023) Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases. Front Aging Neurosci 14:1100133","journal-title":"Front Aging Neurosci"},{"key":"5258_CR67","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035212","volume":"12","author":"S Schrank","year":"2020","unstructured":"Schrank S, Barrington N, Stutzmann GE (2020) Calcium-handling defects and neurodegenerative disease. Cold Spring Harb Perspect Biol 12:a035212","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5258_CR68","doi-asserted-by":"publisher","first-page":"13243","DOI":"10.3390\/ijms241713243","volume":"24","author":"G Griffioen","year":"2023","unstructured":"Griffioen G (2023) Calcium dyshomeostasis drives pathophysiology and neuronal demise in age-related neurodegenerative diseases. Int J Mol Sci 24:13243","journal-title":"Int J Mol Sci"},{"key":"5258_CR69","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1089\/ars.2010.3359","volume":"14","author":"G Z\u00fcndorf","year":"2011","unstructured":"Z\u00fcndorf G, Reiser G (2011) Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 14:1275\u20131288","journal-title":"Antioxid Redox Signal"},{"key":"5258_CR70","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/ijms22094914","volume":"22","author":"R Cascella","year":"2021","unstructured":"Cascella R, Cecchi C (2021) Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 22:4914","journal-title":"Int J Mol Sci"},{"key":"5258_CR71","doi-asserted-by":"publisher","first-page":"7299778","DOI":"10.1155\/2022\/7299778","volume":"2022","author":"B Aryal","year":"2022","unstructured":"Aryal B, Raut BK, Bhattarai S, Bhandari S, Tandan P, Gyawali K, Sharma K, Ranabhat D, Thapa R, Aryal D (2022) Potential therapeutic applications of plant-derived alkaloids against inflammatory and neurodegenerative diseases. Evid Based Complement Altern Med 2022:7299778","journal-title":"Evid Based Complement Altern Med"},{"key":"5258_CR72","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2174\/138920101707160503201541","volume":"17","author":"KM Chaves","year":"2016","unstructured":"Chaves KM, S, M. Feitosa C and da S. Ara\u00fajo L, (2016) Alkaloids pharmacological activities-prospects for the development of phytopharmaceuticals for neurodegenerative diseases. Curr Pharm Biotechnol 17:629\u2013635","journal-title":"Curr Pharm Biotechnol"},{"key":"5258_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.31254\/jahm.2015.1307","volume":"1","author":"S Girdhar","year":"2015","unstructured":"Girdhar S, Girdhar A, Verma SK, Lather V, Pandita D (2015) Plant derived alkaloids in major neurodegenerative diseases: from animal models to clinical trials. J Ayurvedic Herbal Med 1:91\u2013100","journal-title":"J Ayurvedic Herbal Med"},{"key":"5258_CR74","doi-asserted-by":"publisher","first-page":"413808","DOI":"10.1155\/2013\/413808","volume":"2013","author":"A Prasansuklab","year":"2013","unstructured":"Prasansuklab A, Tencomnao T (2013) Amyloidosis in Alzheimer\u2019s disease: the toxicity of Amyloid Beta (A\u03b2), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid Based Complement Altern Med 2013:413808","journal-title":"Evid Based Complement Altern Med"},{"key":"5258_CR75","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fnagi.2018.00359","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Fu Z, Meng L, He M, Zhang Z (2018) The early events that initiate \u03b2-amyloid aggregation in Alzheimer\u2019s disease. Front Aging Neurosci 10:359","journal-title":"Front Aging Neurosci"},{"key":"5258_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103722","volume":"98","author":"E Plazas","year":"2020","unstructured":"Plazas E, Hagenow S, Murillo MA, Stark H, Cuca LE (2020) Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and A\u03b21-42 aggregation. Bioorg Chem 98:103722","journal-title":"Bioorg Chem"},{"key":"5258_CR77","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/1871524919666190820160053","volume":"19","author":"AK Singh","year":"2019","unstructured":"Singh AK, Singh SK, Nandi MK, Mishra G, Maurya A, Rai A, Rai GK, Awasthi R, Sharma B, Kulkarni GT (2019) Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer\u2019s disease. Central Nerv Syst Agents Med Chem 19:154\u2013170","journal-title":"Central Nerv Syst Agents Med Chem"},{"key":"5258_CR78","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.fct.2017.11.025","volume":"111","author":"HM Hussien","year":"2018","unstructured":"Hussien HM, Abd-Elmegied A, Ghareeb DA, Hafez HS, Ahmed HE, Abd El-moneam N (2018) Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer\u2019s-like disease in rats. Food Chem Toxicol 111:432\u2013444","journal-title":"Food Chem Toxicol"},{"key":"5258_CR79","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5114\/aoms.2013.33354","volume":"9","author":"N Panahi","year":"2013","unstructured":"Panahi N, Mahmoudian M, Mortazavi P, Hashjin GS (2013) Experimental research effects of berberine on \u03b2-secretase activity in a rabbit model of Alzheimer\u2019s disease. Arch Med Sci 9:146\u2013150","journal-title":"Arch Med Sci"},{"key":"5258_CR80","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2174\/1567205015666180702105740","volume":"15","author":"Z Cai","year":"2018","unstructured":"Cai Z, Wang C, He W, Chen Y (2018) Berberine alleviates amyloid-beta pathology in the brain of APP\/PS1 transgenic mice via inhibiting \u03b2\/\u03b3-secretases activity and enhancing \u03b1-secretases. Curr Alzheimer Res 15:1045\u20131052","journal-title":"Curr Alzheimer Res"},{"key":"5258_CR81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JAD-2012-120880","volume":"32","author":"JN Fawver","year":"2012","unstructured":"Fawver JN, Duong KT, Wise-Scira O, Petrofes Chapa R, Schall HE, Coskuner O, Zhu X, Colom LV, Murray IV (2012) Probing and trapping a sensitive conformation: amyloid-\u03b2 fibrils, oligomers, and dimers. J Alzheimers Dis 32:197\u2013215","journal-title":"J Alzheimers Dis"},{"key":"5258_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ddr.21587","volume":"81","author":"P Patil","year":"2020","unstructured":"Patil P, Thakur A, Sharma A, Flora SJS (2020) Natural products and their derivatives as multifunctional ligands against Alzheimer\u2019s disease. Drug Dev Res 81:165\u2013183","journal-title":"Drug Dev Res"},{"key":"5258_CR83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fneur.2011.00068","volume":"2","author":"SE Seidl","year":"2011","unstructured":"Seidl SE, Potashkin JA (2011) The promise of neuroprotective agents in Parkinson\u2019s disease. Front Neurol 2:68","journal-title":"Front Neurol"},{"key":"5258_CR84","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12272-014-0397-2","volume":"38","author":"Y-Y Zhu","year":"2015","unstructured":"Zhu Y-Y, Li X, Yu H-Y, Xiong Y-F, Zhang P, Pi H-F, Ruan H-L (2015) Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities. Arch Pharmacal Res 38:604\u2013613","journal-title":"Arch Pharmacal Res"},{"key":"5258_CR85","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0168-0102(03)00097-X","volume":"46","author":"TH Park","year":"2003","unstructured":"Park TH, Kwon OS, Park SY, Han ES, Lee CS (2003) N-methylated \u03b2-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change. Neurosci Res 46:349\u2013358","journal-title":"Neurosci Res"},{"key":"5258_CR86","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1046\/j.0953-816x.2001.01563.x","volume":"13","author":"DH Kim","year":"2001","unstructured":"Kim DH, Jang YY, Han ES, Lee CS (2001) Protective effect of harmaline and harmalol against dopamine-and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. Eur J Neurosci 13:1861\u20131872","journal-title":"Eur J Neurosci"},{"key":"5258_CR87","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1471-4159.2000.0750521.x","volume":"75","author":"CS Lee","year":"2000","unstructured":"Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE (2000) Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. J Neurochem 75:521\u2013531","journal-title":"J Neurochem"},{"key":"5258_CR88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/A:1014832520809","volume":"27","author":"CS Lee","year":"2002","unstructured":"Lee CS, Lee CS, Ko HH, Song JH, Han ES (2002) Effect of R-(-)-deprenyl and harmaline on dopamine-and peroxynitrite-induced membrane permeability transition in brain mitochondria. Neurochem Res 27:215\u2013224","journal-title":"Neurochem Res"},{"key":"5258_CR89","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-319-08894-5_9","volume-title":"Glutamate and ATP at the interface of metabolism and signaling in the brain","author":"Y-B Ouyang","year":"2014","unstructured":"Ouyang Y-B, Xu L, Liu S, Giffard RG (2014) Role of astrocytes in delayed neuronal death: GLT-1 and its novel regulation by microRNAs. Glutamate and ATP at the interface of metabolism and signaling in the brain. Springer, Cham, pp 171\u2013188"},{"key":"5258_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2016.1260189","volume":"49","author":"RG Dos Santos","year":"2017","unstructured":"Dos Santos RG, Hallak JE (2017) Effects of the natural \u03b2-carboline alkaloid harmine, a main constituent of ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies. J Psychoactive Drugs 49:1\u201310","journal-title":"J Psychoactive Drugs"},{"key":"5258_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152842","volume":"61","author":"C-Z Cai","year":"2019","unstructured":"Cai C-Z, Zhou H-F, Yuan N-N, Wu M-Y, Lee SM-Y, Ren J-Y, Su H-X, Lu J-J, Chen X-P, Li M (2019) Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation. Phytomedicine 61:152842","journal-title":"Phytomedicine"},{"key":"5258_CR92","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover A, Kwon YT (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47:e147\u2013e147","journal-title":"Exp Mol Med"},{"key":"5258_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/WNR.0000000000001365","volume":"31","author":"H Deng","year":"2020","unstructured":"Deng H, Jia Y, Pan D, Ma Z (2020) Berberine alleviates rotenone-induced cytotoxicity by antioxidation and activation of PI3K\/Akt signaling pathway in SH-SY5Y cells. NeuroReport 31:41\u201347","journal-title":"NeuroReport"},{"key":"5258_CR94","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10571-019-00756-7","volume":"40","author":"Z Li","year":"2020","unstructured":"Li Z, Jiang T, Lu Q, Xu K, He J, Xie L, Chen Z, Zheng Z, Ye L, Xu K (2020) Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells. Cell Mol Neurobiol 40:587\u2013602","journal-title":"Cell Mol Neurobiol"},{"key":"5258_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153007","volume":"63","author":"G Deng","year":"2019","unstructured":"Deng G, Wu C, Rong X, Li S, Ju Z, Wang Y, Ma C, Ding W, Guan H, Cheng X (2019) Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice. Phytomedicine 63:153007","journal-title":"Phytomedicine"},{"key":"5258_CR96","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021287","volume":"7","author":"B Winner","year":"2015","unstructured":"Winner B, Winkler J (2015) Adult neurogenesis in neurodegenerative diseases. Cold Spring Harb Perspect Biol 7:a021287","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5258_CR97","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","volume":"25","author":"EP Moreno-Jim\u00e9nez","year":"2019","unstructured":"Moreno-Jim\u00e9nez EP, Flor-Garc\u00eda M, Terreros-Roncal J, R\u00e1bano A, Cafini F, Pallas-Bazarra N, \u00c1vila J, Llorens-Mart\u00edn M (2019) Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease. Nat Med 25:554\u2013560","journal-title":"Nat Med"},{"issue":"974\u2013982","key":"5258_CR98","volume":"24","author":"MK Tobin","year":"2019","unstructured":"Tobin MK, Musaraca K, Disouky A, Shetti A, Bheri A, Honer WG, Kim N, Dawe RJ, Bennett DA, Arfanakis K (2019) Human hippocampal neurogenesis persists in aged adults and Alzheimer\u2019s disease patients. Cell Stem Cell 24(974\u2013982):e3","journal-title":"Cell Stem Cell"},{"key":"5258_CR99","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","volume":"7","author":"JA Morales-Garc\u00eda","year":"2017","unstructured":"Morales-Garc\u00eda JA, De la Fuente RM, Alonso-Gil S, Rodr\u00edguez-Franco MI, Feilding A, Perez-Castillo A, Riba J (2017) The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro. Sci Rep 7:5309","journal-title":"Sci Rep"},{"key":"5258_CR100","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11418-019-01368-7","volume":"74","author":"M Yano","year":"2020","unstructured":"Yano M, Nakashima S, Oda Y, Nakamura S, Matsuda H (2020) BBB-permeable aporphine-type alkaloids in Nelumbo nucifera flowers with accelerative effects on neurite outgrowth in PC-12 cells. J Nat Med 74:212\u2013218","journal-title":"J Nat Med"},{"key":"5258_CR101","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339","journal-title":"Cell"},{"key":"5258_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1\u201314","journal-title":"J Neuropathol Exp Neurol"},{"key":"5258_CR103","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160","journal-title":"Nat Rev Neurosci"},{"key":"5258_CR104","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.14037","volume":"143","author":"A Grimm","year":"2017","unstructured":"Grimm A, Eckert A (2017) Brain aging and neurodegeneration: from a mitochondrial point of view. J Neurochem 143:418\u2013431","journal-title":"J Neurochem"},{"key":"5258_CR105","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3233\/JAD-170732","volume":"62","author":"P Mecocci","year":"2018","unstructured":"Mecocci P, Boccardi V, Cecchetti R, Bastiani P, Scamosci M, Ruggiero C, Baroni M (2018) A long journey into aging, brain aging, and Alzheimer\u2019s disease following the oxidative stress tracks. J Alzheimers Dis 62:1319\u20131335","journal-title":"J Alzheimers Dis"},{"key":"5258_CR106","first-page":"1219","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM (2014) The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochem Biophys Acta 1842:1219\u20131231","journal-title":"Biochem Biophys Acta"},{"key":"5258_CR107","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cm","year":"2018","unstructured":"Cm C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464","journal-title":"Redox Biol"},{"key":"5258_CR108","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biochi.2020.02.003","volume":"171","author":"S Elangovan","year":"2020","unstructured":"Elangovan S, Holsinger RD (2020) Cyclical amyloid beta-astrocyte activity induces oxidative stress in Alzheimer\u2019s disease. Biochimie 171:38\u201342","journal-title":"Biochimie"},{"key":"5258_CR109","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","volume":"68","author":"RJ Mark","year":"1997","unstructured":"Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid \u03b2-peptide. J Neurochem 68:255\u2013264","journal-title":"J Neurochem"},{"key":"5258_CR110","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1046\/j.1471-4159.1999.0720734.x","volume":"72","author":"E Liu","year":"1999","unstructured":"Liu E, Halliwell B, Yhlen B, Anggard E, Nourooz-Zadeh J (1999) F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer\u2019s disease. J Neurochem 72:734\u2013740","journal-title":"J Neurochem"},{"key":"5258_CR111","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","volume":"111","author":"F Di Domenico","year":"2017","unstructured":"Di Domenico F, Tramutola A, Butterfield DA (2017) Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders. Free Radical Biol Med 111:253\u2013261","journal-title":"Free Radical Biol Med"},{"key":"5258_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101049","volume":"64","author":"DA Butterfield","year":"2020","unstructured":"Butterfield DA (2020) Brain lipid peroxidation and Alzheimer disease: synergy between the Butterfield and Mattson laboratories. Ageing Res Rev 64:101049","journal-title":"Ageing Res Rev"},{"key":"5258_CR113","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"107","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker A, Cotman CW (2021) Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease. Neurobiol Aging 107:86\u201395","journal-title":"Neurobiol Aging"},{"key":"5258_CR114","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Sch\u00fctt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16:1421\u20131433","journal-title":"Antioxid Redox Signal"},{"key":"5258_CR115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1471-4159.2008.05347.x","volume":"106","author":"PB Shelat","year":"2008","unstructured":"Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106:45\u201355","journal-title":"J Neurochem"},{"key":"5258_CR116","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainres.2005.06.025","volume":"1054","author":"L Nanetti","year":"2005","unstructured":"Nanetti L, Vignini A, Moroni C, Bartolini M, Luzzi S, Provinciali L, Mazzanti L (2005) Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from Alzheimer patients. Brain Res 1054:38\u201344","journal-title":"Brain Res"},{"key":"5258_CR117","volume":"9","author":"S-P Li","year":"2018","unstructured":"Li S-P, Wang Y-W, Qi S-L, Zhang Y-P, Deng G, Ding W-Z, Ma C, Lin Q-Y, Guan H-D, Liu W (2018) Analogous \u03b2-carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol 9:351160","journal-title":"Front Pharmacol"},{"key":"5258_CR118","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1248\/bpb.32.1433","volume":"32","author":"HA Jung","year":"2009","unstructured":"Jung HA, Min B-S, Yokozawa T, Lee J-H, Kim YS, Choi JS (2009) Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol Pharm Bull 32:1433\u20131438","journal-title":"Biol Pharm Bull"},{"key":"5258_CR119","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","volume":"1","author":"S Fahn","year":"2004","unstructured":"Fahn S, Sulzer D (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx 1:139\u2013154","journal-title":"NeuroRx"},{"key":"5258_CR120","doi-asserted-by":"publisher","DOI":"10.2174\/0929867331666230913100624","author":"A Shome","year":"2024","unstructured":"Shome A, Chawla V, Chawla PA (2024) Neuroprotective effect of natural indole and \u03b2-carboline alkaloids against Parkinson\u2019s disease: an overview. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867331666230913100624","journal-title":"Curr Med Chem"},{"key":"5258_CR121","doi-asserted-by":"crossref","unstructured":"Correia AO, Cruz AAP, Aquino ATRd, Diniz JRG, Santana KBF, Cidade PIM, Peixoto JD, Lucetti DL, Nobre MEP, Cruz GMPd (2015) Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson's disease model in rats. J Neurol Ther 1:1-8","DOI":"10.14312\/2397-1304.2015-1"},{"key":"5258_CR122","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","volume":"93","author":"A Yoritaka","year":"1996","unstructured":"Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci 93:2696\u20132701","journal-title":"Proc Natl Acad Sci"},{"key":"5258_CR123","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","volume":"69","author":"Z Alam","year":"1997","unstructured":"Alam Z, Jenner A, Daniel S, Lees A, Cairns N, Marsden C, Jenner P, Halliwell B (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196\u20131203","journal-title":"J Neurochem"},{"key":"5258_CR124","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","volume":"88","author":"JR Richardson","year":"2005","unstructured":"Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88:193\u2013201","journal-title":"Toxicol Sci"},{"key":"5258_CR125","doi-asserted-by":"publisher","first-page":"18536","DOI":"10.1074\/jbc.M413224200","volume":"280","author":"J Callio","year":"2005","unstructured":"Callio J, Oury TD, Chu CT (2005) Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem 280:18536\u201318542","journal-title":"J Biol Chem"},{"key":"5258_CR126","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0197-4580(97)00037-7","volume":"18","author":"J Fowler","year":"1997","unstructured":"Fowler J, Volkow N, Wang G-J, Logan J, Pappas N, Shea C, MacGregor R (1997) Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging 18:431\u2013435","journal-title":"Neurobiol Aging"},{"key":"5258_CR127","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0197-4580(97)00113-9","volume":"18","author":"J Saura","year":"1997","unstructured":"Saura J, Andres N, Andrade C, Ojuel J, Eriksson K, Mahy N (1997) Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 18:497\u2013507","journal-title":"Neurobiol Aging"},{"key":"5258_CR128","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/MN:30:1:077","volume":"30","author":"MJ Kumar","year":"2004","unstructured":"Kumar MJ, Andersen JK (2004) Perspectives on MAO-B in aging and neurological disease: where do we go from here? Mol Neurobiol 30:77\u201389","journal-title":"Mol Neurobiol"},{"key":"5258_CR129","volume":"2012","author":"P Mu\u00f1oz","year":"2012","unstructured":"Mu\u00f1oz P, Huenchuguala S, Paris I, Segura-Aguilar J (2012) Dopamine oxidation and autophagy. Parkinson\u2019s Dis 2012:920953","journal-title":"Parkinson's Dis"},{"key":"5258_CR130","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","volume":"41","author":"TG Hastings","year":"2009","unstructured":"Hastings TG (2009) The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson\u2019s disease. J Bioenerg Biomembr 41:469\u2013472","journal-title":"J Bioenerg Biomembr"},{"key":"5258_CR131","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0021-9258(17)42072-2","volume":"269","author":"MB Yim","year":"1994","unstructured":"Yim MB, Chae HZ, Rhee SG, Chock PB, Stadtman ER (1994) On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J Biol Chem 269:1621\u20131626","journal-title":"J Biol Chem"},{"key":"5258_CR132","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348\u2013355","journal-title":"Ann Neurol"},{"key":"5258_CR133","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"D Dexter","year":"1991","unstructured":"Dexter D, Carayon A, Javoy-Agid F, Agid Y, Wells F, Daniel S, Lees A, Jenner P, Marsden C (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953\u20131975","journal-title":"Brain"},{"key":"5258_CR134","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10534-012-9523-0","volume":"25","author":"MT N\u00fa\u00f1ez","year":"2012","unstructured":"N\u00fa\u00f1ez MT, Urrutia P, Mena N, Aguirre P, Tapia V, Salazar J (2012) Iron toxicity in neurodegeneration. Biometals 25:761\u2013776","journal-title":"Biometals"},{"key":"5258_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101896","volume":"41","author":"L Ma","year":"2021","unstructured":"Ma L, Azad MG, Dharmasivam M, Richardson V, Quinn R, Feng Y, Pountney D, Tonissen K, Mellick G, Yanatori I (2021) Parkinson\u2019s disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 41:101896","journal-title":"Redox Biol"},{"key":"5258_CR136","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1089\/ars.2011.4033","volume":"16","author":"TN Martinez","year":"2012","unstructured":"Martinez TN, Greenamyre JT (2012) Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease. Antioxid Redox Signal 16:920\u2013934","journal-title":"Antioxid Redox Signal"},{"key":"5258_CR137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-011-0828-9","volume":"122","author":"M Elstner","year":"2011","unstructured":"Elstner M, Morris CM, Heim K, Bender A, Mehta D, Jaros E, Klopstock T, Meitinger T, Turnbull DM, Prokisch H (2011) Expression analysis of dopaminergic neurons in Parkinson\u2019s disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol 122:75\u201386","journal-title":"Acta Neuropathol"},{"key":"5258_CR138","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","volume":"21","author":"E Paxinou","year":"2001","unstructured":"Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VM-Y, Ischiropoulos H (2001) Induction of \u03b1-synuclein aggregation by intracellular nitrative insult. J Neurosci 21:8053\u20138061","journal-title":"J Neurosci"},{"key":"5258_CR139","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004010050001","volume":"100","author":"RJ Castellani","year":"2000","unstructured":"Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson\u2019s disease. Acta Neuropathol 100:111\u2013114","journal-title":"Acta Neuropathol"},{"key":"5258_CR140","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3109\/13880209.2014.991835","volume":"53","author":"Y Bi","year":"2015","unstructured":"Bi Y, Qu P-C, Wang Q-S, Zheng L, Liu H-L, Luo R, Chen X-Q, Ba Y-Y, Wu X, Yang H (2015) Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson\u2019s disease. Pharm Biol 53:1516\u20131524","journal-title":"Pharm Biol"},{"key":"5258_CR141","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/md20030191","volume":"20","author":"X Xiao","year":"2022","unstructured":"Xiao X, Tong Z, Zhang Y, Zhou H, Luo M, Hu T, Hu P, Kong L, Liu Z, Yu C (2022) Novel prenylated indole alkaloids with neuroprotection on SH-SY5Y cells against oxidative stress targeting Keap1\u2013Nrf2. Mar Drugs 20:191","journal-title":"Mar Drugs"},{"key":"5258_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jbt.20138","volume":"20","author":"R Soto-Otero","year":"2006","unstructured":"Soto-Otero R, Sanmart\u00edn-Su\u00e1rez C, S\u00e1nchez-Iglesias S, Hermida-Ameijeiras \u00c1, S\u00e1nchez-Sellero I, M\u00e9ndez-\u00c1lvarez E (2006) Study on the ability of 1, 2, 3, 4-tetrahydropapaveroline to cause oxidative stress: mechanisms and potential implications in relation to Parkinson\u2019s disease. J Biochem Mol Toxicol 20:209\u2013220","journal-title":"J Biochem Mol Toxicol"},{"key":"5258_CR143","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.3390\/molecules24112182","volume":"24","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Beiram R, Azimullah S, Meeran MFN, Ojha SK, Adem A, Jalal FY (2019) Lycopodium attenuates loss of dopaminergic neurons by suppressing oxidative stress and neuroinflammation in a rat model of Parkinson\u2019s disease. Molecules 24:2182","journal-title":"Molecules"},{"key":"5258_CR144","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1389450115666140115113734","volume":"15","author":"J Gil-Mohapel","year":"2014","unstructured":"Gil-Mohapel J, Brocardo SP, Christie B (2014) The role of oxidative stress in Huntington\u2019s disease: are antioxidants good therapeutic candidates? Curr Drug Targets 15:454\u2013468","journal-title":"Curr Drug Targets"},{"key":"5258_CR145","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1021\/jm200605a","volume":"54","author":"I T\u00fanez","year":"2011","unstructured":"T\u00fanez I, S\u00e1nchez-L\u00f3pez F, Ag\u00fcera E, Fern\u00e1ndez-Bola\u00f1os R, S\u00e1nchez FM, Tasset-Cuevas I (2011) Important role of oxidative stress biomarkers in Huntington\u2019s disease. J Med Chem 54:5602\u20135606","journal-title":"J Med Chem"},{"key":"5258_CR146","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"5258_CR147","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel J, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"5258_CR148","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, Macdonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41:689\u2013692","journal-title":"Ann Neurol"},{"key":"5258_CR149","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden M and Group aIHsDC","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden M and Group aIHsDC (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65:267\u2013277","journal-title":"Clin Genet"},{"key":"5258_CR150","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JPG Vonsattel","year":"1998","unstructured":"Vonsattel JPG, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369","journal-title":"J Neuropathol Exp Neurol"},{"key":"5258_CR151","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1427.008","volume":"1147","author":"EC Stack","year":"2008","unstructured":"Stack EC, Matson WR, Ferrante RJ (2008) Evidence of oxidant damage in Huntington\u2019s disease: translational strategies using antioxidants. Ann NY Acad Sci 1147:79\u201392","journal-title":"Ann NY Acad Sci"},{"key":"5258_CR152","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","volume":"121","author":"J Lee","year":"2011","unstructured":"Lee J, Kosaras B, Del Signore SJ, Cormier K, McKee A, Ratan RR, Kowall NW, Ryu H (2011) Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington\u2019s disease mice. Acta Neuropathol 121:487\u2013498","journal-title":"Acta Neuropathol"},{"key":"5258_CR153","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200905138","volume":"189","author":"Y Enokido","year":"2010","unstructured":"Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H, Sone M, Foulle R, Sawada H, Ishiguro H (2010) Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol 189:425\u2013443","journal-title":"J Cell Biol"},{"key":"5258_CR154","doi-asserted-by":"publisher","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","volume":"286","author":"S Hands","year":"2011","unstructured":"Hands S, Sajjad MU, Newton MJ, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286:44512\u201344520","journal-title":"J Biol Chem"},{"key":"5258_CR155","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ (2005) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 37:526\u2013531","journal-title":"Nat Genet"},{"key":"5258_CR156","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","volume":"49","author":"MA Sorolla","year":"2010","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Tamarit J, Ortega Z, Lucas JJ, Ferrer I, Ros J, Cabiscol E (2010) Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radical Biol Med 49:612\u2013621","journal-title":"Free Radical Biol Med"},{"key":"5258_CR157","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","volume":"45","author":"MA Sorolla","year":"2008","unstructured":"Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radical Biol Med 45:667\u2013678","journal-title":"Free Radical Biol Med"},{"key":"5258_CR158","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway. Cell Death Differ 16:899\u2013909","journal-title":"Cell Death Differ"},{"key":"5258_CR159","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.dnarep.2008.03.012","volume":"7","author":"J-L Yang","year":"2008","unstructured":"Yang J-L, Weissman L, Bohr VA, Mattson MP (2008) Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair 7:1110\u20131120","journal-title":"DNA Repair"},{"key":"5258_CR160","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","volume":"53","author":"A Siddiqui","year":"2012","unstructured":"Siddiqui A, Rivera-S\u00e1nchez S, Castro MdR, Acevedo-Torres K, Rane A, Torres-Ramos CA, Nicholls DG, Andersen JK, Ayala-Torres S (2012) Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease. Free Radical Biol Med 53:1478\u20131488","journal-title":"Free Radical Biol Med"},{"key":"5258_CR161","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","volume":"53","author":"N Brustovetsky","year":"2016","unstructured":"Brustovetsky N (2016) Mutant huntingtin and elusive defects in oxidative metabolism and mitochondrial calcium handling. Mol Neurobiol 53:2944\u20132953","journal-title":"Mol Neurobiol"},{"key":"5258_CR162","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1042\/BST0340232","volume":"34","author":"A Halestrap","year":"2006","unstructured":"Halestrap A (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34:232\u2013237","journal-title":"Biochem Soc Trans"},{"key":"5258_CR163","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.febslet.2010.02.022","volume":"584","author":"A Rasola","year":"2010","unstructured":"Rasola A, Sciacovelli M, Pantic B, Bernardi P (2010) Signal transduction to the permeability transition pore. FEBS Lett 584:1989\u20131996","journal-title":"FEBS Lett"},{"key":"5258_CR164","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171","journal-title":"Surg Neurol Int"},{"key":"5258_CR165","first-page":"189","volume":"86","author":"M Tanaka","year":"2016","unstructured":"Tanaka M, Sakata T, Palumbo J, Akimoto M (2016) A 24-week, phase III, double-blind, parallel-group study of edaravone (MCI-186) for treatment of amyotrophic lateral sclerosis (ALS)(P3. 189). Neurology 86:189","journal-title":"Neurology"},{"key":"5258_CR166","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","volume":"383","author":"S Paganoni","year":"2020","unstructured":"Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A (2020) Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis. N Engl J Med 383:919\u2013930","journal-title":"N Engl J Med"},{"key":"5258_CR167","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1212\/01.wnl.0000296811.19811.db","volume":"70","author":"PN Valdmanis","year":"2008","unstructured":"Valdmanis PN, Rouleau GA (2008) Genetics of familial amyotrophic lateral sclerosis. Neurology 70:144\u2013152","journal-title":"Neurology"},{"key":"5258_CR168","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuint.2008.01.009","volume":"52","author":"GN Babu","year":"2008","unstructured":"Babu GN, Kumar A, Chandra R, Puri S, Singh R, Kalita J, Misra U (2008) Oxidant\u2013antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int 52:1284\u20131289","journal-title":"Neurochem Int"},{"key":"5258_CR169","doi-asserted-by":"publisher","first-page":"13860","DOI":"10.1073\/pnas.0605814103","volume":"103","author":"A Ferri","year":"2006","unstructured":"Ferri A, Cozzolino M, Crosio C, Nencini M, Casciati A, Gralla EB, Rotilio G, Valentine JS, Carri MT (2006) Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci 103:13860\u201313865","journal-title":"Proc Natl Acad Sci"},{"key":"5258_CR170","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0009-2797(02)00160-6","volume":"145","author":"GJ den Hartog","year":"2003","unstructured":"den Hartog GJ, Haenen GR, Vegt E, van der Vijgh WJ, Bast A (2003) Superoxide dismutase: the balance between prevention and induction of oxidative damage. Chem Biol Interact 145:33\u201339","journal-title":"Chem Biol Interact"},{"key":"5258_CR171","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0197-0186(01)00125-5","volume":"40","author":"FM Menzies","year":"2002","unstructured":"Menzies FM, Ince PG, Shaw PJ (2002) Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 40:543\u2013551","journal-title":"Neurochem Int"},{"key":"5258_CR172","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/hmg\/ddm110","volume":"16","author":"D Sau","year":"2007","unstructured":"Sau D, De Biasi S, Vitellaro-Zuccarello L, Riso P, Guarnieri S, Porrini M, Simeoni S, Crippa V, Onesto E, Palazzolo I (2007) Mutation of SOD1 in ALS: a gain of a loss of function. Hum Mol Genet 16:1604\u20131618","journal-title":"Hum Mol Genet"},{"key":"5258_CR173","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1038\/s41598-019-47326-x","volume":"9","author":"S Bakavayev","year":"2019","unstructured":"Bakavayev S, Chetrit N, Zvagelsky T, Mansour R, Vyazmensky M, Barak Z, Israelson A, Engel S (2019) Cu\/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit. Sci Rep 9:10826","journal-title":"Sci Rep"},{"key":"5258_CR174","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/364584a0","volume":"364","author":"JS Beckman","year":"1993","unstructured":"Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364:584\u2013584","journal-title":"Nature"},{"key":"5258_CR175","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.2174\/1568026611212220010","volume":"12","author":"Y Sheng","year":"2012","unstructured":"Sheng Y, Chattopadhyay M, Whitelegge J, Selverstone Valentine J (2012) SOD1 aggregation and ALS: role of metallation states and disulfide status. Curr Top Med Chem 12:2560\u20132572","journal-title":"Curr Top Med Chem"},{"key":"5258_CR176","doi-asserted-by":"publisher","first-page":"25371","DOI":"10.1016\/S0021-9258(19)74050-2","volume":"267","author":"K Sato","year":"1992","unstructured":"Sato K, Akaike T, Kohno M, Ando M, Maeda H (1992) Hydroxyl radical production by H2O2 plus Cu, Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme. J Biol Chem 267:25371\u201325377","journal-title":"J Biol Chem"},{"key":"5258_CR177","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.bpj.2016.02.037","volume":"110","author":"D Petrov","year":"2016","unstructured":"Petrov D, Daura X, Zagrovic B (2016) Effect of oxidative damage on the stability and dimerization of superoxide dismutase 1. Biophys J 110:1499\u20131509","journal-title":"Biophys J"},{"key":"5258_CR178","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1038\/s41467-018-06111-6","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Guo W, Mitra J, Hegde PM, Vandoorne T, Eckelmann BJ, Mitra S, Tomkinson AE, Van Den Bosch L, Hegde ML (2018) Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in amyotrophic lateral sclerosis. Nat Commun 9:3683","journal-title":"Nat Commun"},{"key":"5258_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134523","volume":"713","author":"JD Lai","year":"2019","unstructured":"Lai JD, Ichida JK (2019) C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis. Neurosci Lett 713:134523","journal-title":"Neurosci Lett"},{"key":"5258_CR180","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","volume":"92","author":"R Lopez-Gonzalez","year":"2016","unstructured":"Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, Petrucelli L, Miller BL, Almeida S, Gao F-B (2016) Poly (GR) in C9ORF72-related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 92:383\u2013391","journal-title":"Neuron"},{"key":"5258_CR181","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.10.016","volume":"60","author":"Y Li","year":"2011","unstructured":"Li Y, Sattler R, Yang EJ, Nunes A, Ayukawa Y, Akhtar S, Ji G, Zhang P-W, Rothstein JD (2011) Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology 60:1168\u20131175","journal-title":"Neuropharmacology"},{"key":"5258_CR182","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1208\/s12248-017-0120-6","volume":"19","author":"LA Mohamed","year":"2017","unstructured":"Mohamed LA, Markandaiah S, Bonanno S, Pasinelli P, Trotti D (2017) Blood\u2013brain barrier driven pharmacoresistance in amyotrophic lateral sclerosis and challenges for effective drug therapies. AAPS J 19:1600\u20131614","journal-title":"AAPS J"},{"key":"5258_CR183","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/md12010525","volume":"12","author":"D Lopez","year":"2014","unstructured":"Lopez D, Martinez-Luis S (2014) Marine natural products with P-glycoprotein inhibitor properties. Mar Drugs 12:525\u2013546","journal-title":"Mar Drugs"},{"key":"5258_CR184","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4236\/pp.2019.103012","volume":"10","author":"FT Zohora","year":"2019","unstructured":"Zohora FT, Islam SN, Khan SA, Hasan CM, Ahsan M (2019) Antioxidant, cytotoxic, thrombolytic and antimicrobial activity of Zanthoxylum rhetsa root bark with two isolated quinolone alkaloids. Pharmacol Pharm 10:137\u2013145","journal-title":"Pharmacol Pharm"},{"key":"5258_CR185","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2018.04.004","volume":"168","author":"TB Soares","year":"2018","unstructured":"Soares TB, Loureiro L, Carvalho A, Oliveira MECR, Dias A, Sarmento B, L\u00facio M (2018) Lipid nanocarriers loaded with natural compounds: potential new therapies for age related neurodegenerative diseases? Prog Neurobiol 168:21\u201341","journal-title":"Prog Neurobiol"},{"key":"5258_CR186","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","volume":"33","author":"SSK Durairajan","year":"2012","unstructured":"Durairajan SSK, Liu L-F, Lu J-H, Chen L-L, Yuan Q, Chung SK, Huang L, Li X-S, Huang J-D, Li M (2012) Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model. Neurobiol Aging 33:2903\u20132919","journal-title":"Neurobiol Aging"},{"key":"5258_CR187","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3892\/ijmm.2014.1656","volume":"33","author":"M Kim","year":"2014","unstructured":"Kim M, Cho K-H, Shin M-S, Lee J-M, Cho H-S, Kim C-J, Shin D-H, Yang HJ (2014) Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson\u2019s disease. Int J Mol Med 33:870\u2013878","journal-title":"Int J Mol Med"},{"key":"5258_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.618787","volume":"11","author":"S Huang","year":"2021","unstructured":"Huang S, Liu H, Lin Y, Liu M, Li Y, Mao H, Zhang Z, Zhang Y, Ye P, Ding L (2021) Berberine protects against NLRP3 inflammasome via ameliorating autophagic impairment in MPTP-induced Parkinson\u2019s disease model. Front Pharmacol 11:618787","journal-title":"Front Pharmacol"},{"key":"5258_CR189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134142","volume":"10","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wei W, Gaertig MA, Li S, Li X-J (2015) Therapeutic effect of berberine on Huntington\u2019s disease transgenic mouse model. PLoS ONE 10:e0134142","journal-title":"PLoS ONE"},{"key":"5258_CR190","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/aps.2010.230","volume":"32","author":"S-m Yuan","year":"2011","unstructured":"Yuan S-m, Gao K, Wang D-m, Quan X-z, Liu J-n, Ma C-m, Qin C, Zhang L-f (2011) Evodiamine improves congnitive abilities in SAMP8 and APPswe\/PS1\u0394E9 transgenic mouse models of Alzheimer\u2019s disease. Acta Pharmacol Sin 32:295\u2013302","journal-title":"Acta Pharmacol Sin"},{"key":"5258_CR191","doi-asserted-by":"publisher","first-page":"1025066","DOI":"10.3389\/fnmol.2022.1025066","volume":"15","author":"S Pang","year":"2023","unstructured":"Pang S, Li S, Cheng H, Luo Z, Qi X, Guan F, Dong W, Gao S, Liu N, Gao X (2023) Discovery of an evodiamine derivative for PI3K\/AKT\/GSK3\u03b2 pathway activation and AD pathology improvement in mouse models. Front Mol Neurosci 15:1025066","journal-title":"Front Mol Neurosci"},{"key":"5258_CR192","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s11064-014-1356-5","volume":"39","author":"T Zhao","year":"2014","unstructured":"Zhao T, Zhang X, Zhao Y, Zhang L, Bai X, Zhang J, Zhao X, Chen L, Wang L, Cui L (2014) Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3\u03b2, down-regulated NF-\u03baB expression, and ameliorated BBB permeability. Neurochem Res 39:1612\u20131620","journal-title":"Neurochem Res"},{"key":"5258_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113435","volume":"153","author":"M Xu","year":"2022","unstructured":"Xu M, Wang W, Lu W, Ling X, Rui Q, Ni H (2022) Evodiamine prevents traumatic brain injury through inhibiting oxidative stress via PGK1\/NRF2 pathway. Biomed Pharmacother 153:113435","journal-title":"Biomed Pharmacother"},{"key":"5258_CR194","doi-asserted-by":"publisher","first-page":"15238","DOI":"10.3390\/ijms232315238","volume":"23","author":"Y-P Yan","year":"2022","unstructured":"Yan Y-P, Chen J-Y, Lu J-H (2022) Disease-modifying activity of huperzine a on Alzheimer\u2019s disease: evidence from preclinical studies on rodent models. Int J Mol Sci 23:15238","journal-title":"Int J Mol Sci"},{"key":"5258_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175970","volume":"956","author":"X Guo","year":"2023","unstructured":"Guo X, Wu Y, Wang Q, Zhang J, Sheng X, Zheng L, Wang Y (2023) Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson\u2019s disease. Eur J Pharmacol 956:175970","journal-title":"Eur J Pharmacol"},{"key":"5258_CR196","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10571-015-0276-5","volume":"36","author":"X-Y Mao","year":"2016","unstructured":"Mao X-Y, Zhou H-H, Li X, Liu Z-Q (2016) Huperzine A alleviates oxidative glutamate toxicity in hippocampal HT22 cells via activating BDNF\/TrkB-dependent PI3K\/Akt\/mTOR signaling pathway. Cell Mol Neurobiol 36:915\u2013925","journal-title":"Cell Mol Neurobiol"},{"key":"5258_CR197","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000336427","volume":"11","author":"M Ratia","year":"2013","unstructured":"Ratia M, Gim\u00e9nez-Llort L, Camps P, Mu\u00f1oz-Torrero D, Perez B, Clos MV, Badia A (2013) Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer\u2019s disease in triple transgenic mice (3xTg-AD). Neurodegener Dis 11:129\u2013140","journal-title":"Neurodegener Dis"},{"key":"5258_CR198","first-page":"143","volume":"27","author":"M Sofiabadi","year":"2020","unstructured":"Sofiabadi M, Esmaeili M, Mafea A-r (2020) Effects of morphine on spatial learning and memory in healthy rats and streptozotocin rat model of Alzheimer\u2019s disease. J Sabzevar Univ Med Sci 27:143\u2013153","journal-title":"J Sabzevar Univ Med Sci"},{"key":"5258_CR199","doi-asserted-by":"publisher","first-page":"23","DOI":"10.29252\/shefa.7.4.23","volume":"7","author":"H Sasan","year":"2019","unstructured":"Sasan H, Samareh Gholami A, Hashemabadi M (2019) Alteration in the expression of Alzheimer\u2019s-related genes in rat hippocampus by exercise and morphine treatments. Neurosci J Shefaye Khatam 7:23\u201329","journal-title":"Neurosci J Shefaye Khatam"},{"key":"5258_CR200","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fnmol.2018.00120","volume":"11","author":"B Wang","year":"2018","unstructured":"Wang B, Su C-J, Liu T-T, Zhou Y, Feng Y, Huang Y, Liu X, Wang Z-H, Chen L-H, Luo W-F (2018) The neuroprotection of low-dose morphine in cellular and animal models of Parkinson\u2019s disease through ameliorating endoplasmic reticulum (ER) stress and activating autophagy. Front Mol Neurosci 11:120","journal-title":"Front Mol Neurosci"},{"key":"5258_CR201","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/JCMA.0000000000000448","volume":"84","author":"Y-Y Liu","year":"2021","unstructured":"Liu Y-Y, Lin Y-C, Hsiao H-T, Wang JC-F, Liu Y-C (2021) Morphine produces better thermal analgesia in young Huntington mice and are associated with less neuroinflammation in spinal cord. J Chin Med Assoc 84:73\u201378","journal-title":"J Chin Med Assoc"},{"key":"5258_CR202","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22429","volume":"34","author":"S Yin","year":"2020","unstructured":"Yin S, Ran Q, Yang J, Zhao Y, Li C (2020) Nootropic effect of neferine on aluminium chloride\u2013induced Alzheimer\u2019s disease in experimental models. J Biochem Mol Toxicol 34:e22429","journal-title":"J Biochem Mol Toxicol"},{"key":"5258_CR203","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/ph15010083","volume":"15","author":"B Tang","year":"2022","unstructured":"Tang B, Zeng W, Song LL, Wang HM, Qu LQ, Lo HH, Yu L, Wu AG, Wong VKW, Law BYK (2022) Extracellular vesicle delivery of neferine for the attenuation of neurodegenerative disease proteins and motor deficit in an Alzheimer\u2019s disease mouse model. Pharmaceuticals 15:83","journal-title":"Pharmaceuticals"},{"key":"5258_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2023.13122","volume":"28","author":"T Li","year":"2023","unstructured":"Li T, Zhai YX, Zheng T, Xu B (2023) Neferine exerts anti-inflammatory activity in BV-2 microglial cells and protects mice with MPTP-induced Parkinson\u2019s disease by inhibiting NF-\u03baB activation. Mol Med Rep 28:1\u20139","journal-title":"Mol Med Rep"},{"key":"5258_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6654954","volume":"2021","author":"J-j Zhu","year":"2021","unstructured":"Zhu J-j, Yu B-y, Huang X-k, He M-z, Chen B-w, Chen T-t, Fang H-y, Chen S-q, X-q Fu, Li P-j (2021) Neferine protects against hypoxic-ischemic brain damage in neonatal rats by suppressing NLRP3-mediated inflammasome activation. Oxid Med Cell Longev 2021:1\u201319","journal-title":"Oxid Med Cell Longev"},{"key":"5258_CR206","first-page":"7293","volume":"17","author":"G Zang","year":"2018","unstructured":"Zang G, Fang L, Chen L, Wang C (2018) Ameliorative effect of nicergoline on cognitive function through the PI3K\/AKT signaling pathway in mouse models of Alzheimer\u2019s disease. Mol Med Rep 17:7293\u20137300","journal-title":"Mol Med Rep"},{"key":"5258_CR207","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0014-2999(99)00623-8","volume":"383","author":"S Asai","year":"1999","unstructured":"Asai S, Zhao H, Yamashita A, Jike T, Kunimatsu T, Nagata T, Kohno T, Ishikawa K (1999) Nicergoline enhances glutamate re-uptake and protects against brain damage in rat global brain ischemia. Eur J Pharmacol 383:267\u2013274","journal-title":"Eur J Pharmacol"},{"key":"5258_CR208","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0304-3940(98)00310-3","volume":"248","author":"M Tanaka","year":"1998","unstructured":"Tanaka M, Yoshida T, Okamoto K, Hirai S (1998) Antioxidant properties of nicergoline; inhibition of brain auto-oxidation and superoxide production of neutrophils in rats. Neurosci Lett 248:68\u201372","journal-title":"Neurosci Lett"},{"key":"5258_CR209","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF02252925","volume":"2","author":"B Saletu","year":"1990","unstructured":"Saletu B, Gr\u00fcnberger J, Linzmayer L, Anderer P (1990) Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry. J Neural Transm Gen Sect 2:305\u2013325","journal-title":"J Neural Transm Gen Sect"},{"key":"5258_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114111","volume":"158","author":"I Kiris","year":"2023","unstructured":"Kiris I, Kukula-Koch W, Karayel-Basar M, Gurel B, Coskun J, Baykal AT (2023) Proteomic alterations in the cerebellum and hippocampus in an Alzheimer\u2019s disease mouse model: alleviating effect of palmatine. Biomed Pharmacother 158:114111","journal-title":"Biomed Pharmacother"},{"key":"5258_CR211","doi-asserted-by":"publisher","first-page":"16542","DOI":"10.3390\/ijms242216542","volume":"24","author":"D-Y Lee","year":"2023","unstructured":"Lee D-Y, Lee K-M, Um J-H, Kim Y-Y, Kim D-H, Yun J (2023) The natural alkaloid palmatine selectively induces mitophagy and restores mitochondrial function in an Alzheimer\u2019s disease mouse model. Int J Mol Sci 24:16542","journal-title":"Int J Mol Sci"},{"key":"5258_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148932","volume":"1835","author":"L Han","year":"2024","unstructured":"Han L, Chen W, Li J, Zhao Y, Zong Y, He Z, Du R (2024) Palmatine improves cognitive dysfunction in Alzheimer\u2019s disease model rats through autophagy pathway and regulation of gut microbiota. Brain Res 1835:148932","journal-title":"Brain Res"},{"key":"5258_CR213","doi-asserted-by":"publisher","first-page":"6660193","DOI":"10.1155\/2021\/6660193","volume":"2021","author":"C Tang","year":"2021","unstructured":"Tang C, Hong J, Hu C, Huang C, Gao J, Huang J, Wang D, Geng Q, Dong Y (2021) Palmatine protects against cerebral ischemia\/reperfusion injury by activation of the AMPK\/Nrf2 pathway. Oxidative Med Cell Longevity 2021:6660193","journal-title":"Oxidative Med Cell Longevity"},{"key":"5258_CR214","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1021\/acschemneuro.1c00600","volume":"12","author":"W-Y Fu","year":"2021","unstructured":"Fu W-Y, Hung K-W, Lau S-F, Butt B, Yuen VW-H, Fu G, Chan IC, Ip FC, Fu AK, Ip NY (2021) Rhynchophylline administration ameliorates amyloid-\u03b2 pathology and inflammation in an Alzheimer\u2019s disease transgenic mouse model. ACS Chem Neurosci 12:4249\u20134256","journal-title":"ACS Chem Neurosci"},{"key":"5258_CR215","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s11064-021-03343-9","volume":"46","author":"P Jiang","year":"2021","unstructured":"Jiang P, Chen L, Xu J, Liu W, Feng F, Qu W (2021) Neuroprotective effects of rhynchophylline against A\u03b21\u201342-Induced oxidative stress, neurodegeneration, and memory impairment Via Nrf2\u2013ARE activation. Neurochem Res 46:2439\u20132450","journal-title":"Neurochem Res"},{"key":"5258_CR216","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2015.11.035","volume":"1631","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sun J, Zhu S, Xu T, Lu J, Han H, Zhou C, Yan J (2016) The role of rhynchophylline in alleviating early brain injury following subarachnoid hemorrhage in rats. Brain Res 1631:92\u2013100","journal-title":"Brain Res"},{"key":"5258_CR217","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.fitote.2010.05.007","volume":"81","author":"J-Y Zhou","year":"2010","unstructured":"Zhou J-Y, Mo Z-X, Zhou S-W (2010) Effect of rhynchophylline on central neurotransmitter levels in amphetamine-induced conditioned place preference rat brain. Fitoterapia 81:844\u2013848","journal-title":"Fitoterapia"},{"key":"5258_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153627","volume":"90","author":"D Ren","year":"2021","unstructured":"Ren D, Fu Y, Wang L, Liu J, Zhong X, Yuan J, Jiang C, Wang H, Li Z (2021) Tetrandrine ameliorated Alzheimer\u2019s disease through suppressing microglial inflammatory activation and neurotoxicity in the 5XFAD mouse. Phytomedicine 90:153627","journal-title":"Phytomedicine"},{"key":"5258_CR219","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2011.01.103","volume":"1384","author":"F-Q He","year":"2011","unstructured":"He F-Q, Qiu B-Y, Zhang X-H, Li T-K, Xie Q, Cui D-J, Huang X-L, Gan H-T (2011) Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-\u03baB activation in a rat model of Alzheimer\u2019s disease induced by amyloid-\u03b2 (1\u201342). Brain Res 1384:89\u201396","journal-title":"Brain Res"},{"key":"5258_CR220","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1179\/1743132813Y.0000000175","volume":"35","author":"L Chen","year":"2013","unstructured":"Chen L, Chen L, Lv Y, Cui Z, Bei G, Qin G, Zhou J, Ge T (2013) Tetrandrine ameliorates cognitive impairment via inhibiting astrocyte-derived S100B activation in a rat model of chronic cerebral hypoperfusion. Neurol Res 35:614\u2013621","journal-title":"Neurol Res"},{"key":"5258_CR221","doi-asserted-by":"crossref","unstructured":"Chen L, Zeng Z and Chen L (2012) Effects of tetrandrine on learning and memory dysfunction and neuronal apoptosis in hippocampus of rats with vascular dementia. 2012 8th International Conference on Natural Computation, IEEE, pp 557\u2013561","DOI":"10.1109\/ICNC.2012.6234562"},{"key":"5258_CR222","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/neu.2017.5102","volume":"35","author":"J Zhao","year":"2018","unstructured":"Zhao J, Hylin MJ, Kobori N, Hood KN, Moore AN, Dash PK (2018) Post-injury administration of galantamine reduces traumatic brain injury pathology and improves outcome. J Neurotrauma 35:362\u2013374","journal-title":"J Neurotrauma"},{"key":"5258_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146424","volume":"1724","author":"LE Sperling","year":"2019","unstructured":"Sperling LE, Reis KP, Nicola F, Teixeira CE, Did\u00f3 GG, Dos Santos MG, Konrath E, Netto CA, Pranke P (2019) Galantamine improves functional recovery and reduces lesion size in a rat model of spinal cord injury. Brain Res 1724:146424","journal-title":"Brain Res"},{"key":"5258_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175810","volume":"952","author":"AA Atta","year":"2023","unstructured":"Atta AA, Ibrahim WW, Mohamed AF, Abdelkader NF (2023) Targeting \u03b17-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: involvement of cAMP\/PKA, PI3K\/AKT, and M1\/M2 microglia polarization. Eur J Pharmacol 952:175810","journal-title":"Eur J Pharmacol"},{"key":"5258_CR225","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/jpet.107.122747","volume":"322","author":"S Lorrio","year":"2007","unstructured":"Lorrio S, Sobrado M, Arias E, Roda JM, Garc\u00eda AG, Lopez MG (2007) Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. J Pharmacol Exp Ther 322:591\u2013599","journal-title":"J Pharmacol Exp Ther"},{"key":"5258_CR226","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1002\/ptr.7539","volume":"36","author":"F Yarmohammadi","year":"2022","unstructured":"Yarmohammadi F, Hayes AW, Karimi G (2022) The therapeutic effects of berberine against different diseases: a review on the involvement of the endoplasmic reticulum stress. Phytother Res 36:3215\u20133231","journal-title":"Phytother Res"},{"key":"5258_CR227","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1021\/acschemneuro.0c00808","volume":"12","author":"Y Liang","year":"2021","unstructured":"Liang Y, Ye C, Chen Y, Chen Y, Diao S, Huang M (2021) Berberine improves behavioral and cognitive deficits in a mouse model of Alzheimer\u2019s disease via regulation of \u03b2-amyloid production and endoplasmic reticulum stress. ACS Chem Neurosci 12:1894\u20131904","journal-title":"ACS Chem Neurosci"},{"key":"5258_CR228","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1007\/s11064-021-03431-w","volume":"46","author":"X Li","year":"2021","unstructured":"Li X, Su Y, Li N, Zhang F-R, Zhang N (2021) Berberine attenuates MPP+-induced neuronal injury by regulating LINC00943\/miR-142-5p\/KPNA4\/NF-\u03baB pathway in SK-N-SH cells. Neurochem Res 46:3286\u20133300","journal-title":"Neurochem Res"},{"key":"5258_CR229","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1007\/s11064-021-03428-5","volume":"46","author":"G Ibrahim Fouad","year":"2021","unstructured":"Ibrahim Fouad G, Ahmed KA (2021) Neuroprotective potential of berberine against doxorubicin-induced toxicity in rat\u2019s brain. Neurochem Res 46:3247\u20133263","journal-title":"Neurochem Res"},{"key":"5258_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845591","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Kang C, Che S, Su J, Sun Q, Ge T, Guo Y, Lv J, Sun Z, Yang W (2022) Berberine: a promising treatment for neurodegenerative diseases. Front Pharmacol 13:845591","journal-title":"Front Pharmacol"},{"key":"5258_CR231","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11427-015-4829-0","volume":"58","author":"W Jiang","year":"2015","unstructured":"Jiang W, Li S, Li X (2015) Therapeutic potential of berberine against neurodegenerative diseases. Sci China Life Sci 58:564\u2013569","journal-title":"Sci China Life Sci"},{"key":"5258_CR232","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-016-0290-z","volume":"23","author":"C-F Chang","year":"2016","unstructured":"Chang C-F, Lee Y-C, Lee K-H, Lin H-C, Chen C-L, Shen C-KJ, Huang C-C (2016) Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J Biomed Sci 23:1\u201312","journal-title":"J Biomed Sci"},{"key":"5258_CR233","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.2147\/IJN.S459510","volume":"19","author":"L Lin","year":"2024","unstructured":"Lin L, Liu Y, Tang R, Ding S, Lin H, Li H (2024) Evodiamine: a extremely potential drug development candidate of alkaloids from Evodia rutaecarpa. Int J Nanomed 19:9843\u20139870","journal-title":"Int J Nanomed"},{"key":"5258_CR234","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/ijms19051527","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang J, Wang C, Li Z, Liu X, Zhang J, Lu J, Wang D (2018) Pharmacological basis for the use of evodiamine in Alzheimer\u2019s disease: antioxidation and antiapoptosis. Int J Mol Sci 19:1527","journal-title":"Int J Mol Sci"},{"key":"5258_CR235","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11571-017-9471-z","volume":"12","author":"D Wang","year":"2018","unstructured":"Wang D, Wang C, Liu L, Li S (2018) Protective effects of evodiamine in experimental paradigm of Alzheimer\u2019s disease. Cogn Neurodyn 12:303\u2013313","journal-title":"Cogn Neurodyn"},{"key":"5258_CR236","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.3390\/ijms22105347","volume":"22","author":"C-H Chou","year":"2021","unstructured":"Chou C-H, Yang C-R (2021) Neuroprotective studies of evodiamine in an okadaic acid-induced neurotoxicity. Int J Mol Sci 22:5347","journal-title":"Int J Mol Sci"},{"key":"5258_CR237","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.1148","author":"X Chen","year":"2023","unstructured":"Chen X, Shao J, Li R, Shao S, Zhang X, Ma M, Sun J, Li N (2023) Effect of evodiamine on 6-hydroxydopamine induced damage of Parkinson\u2019s disease cell model by modulating microrna-9\u20135p. Indian J Pharm Sci. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.1148","journal-title":"Indian J Pharm Sci"},{"key":"5258_CR238","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ame2.12126","volume":"3","author":"S Pang","year":"2020","unstructured":"Pang S, Sun C, Gao S, Yang Y, Pan X, Zhang L (2020) Evodiamine derivatives improve cognitive abilities in APPswe\/PS1\u0394E9 transgenic mouse models of Alzheimer\u2019s disease. Anim Models Exp Med 3:193\u2013199","journal-title":"Anim Models Exp Med"},{"key":"5258_CR239","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","volume":"113","author":"X Ma","year":"2007","unstructured":"Ma X, Tan C, Zhu D, Gang DR, Xiao P (2007) Huperzine A from Huperzia species\u2014an ethnopharmacolgical review. J Ethnopharmacol 113:15\u201334","journal-title":"J Ethnopharmacol"},{"key":"5258_CR240","first-page":"1455","volume":"24","author":"Z Mei","year":"2021","unstructured":"Mei Z, Hong Y, Yang H, Sheng Q, Situ B (2021) Huperzine A protects against traumatic brain injury through anti-oxidative effects via the Nrf2-ARE pathway. Iran J Basic Med Sci 24:1455","journal-title":"Iran J Basic Med Sci"},{"key":"5258_CR241","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3940(00)01088-0","volume":"286","author":"XQ Xiao","year":"2000","unstructured":"Xiao XQ, Wang R, Han YF, Tang XC (2000) Protective effects of huperzine A on \u03b2-amyloid25\u201335 induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett 286:155\u2013158","journal-title":"Neurosci Lett"},{"key":"5258_CR242","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074916","volume":"8","author":"G Yang","year":"2013","unstructured":"Yang G, Wang Y, Tian J, Liu J-P (2013) Huperzine A for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized clinical trials. PLoS ONE 8:e74916","journal-title":"PLoS ONE"},{"key":"5258_CR243","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/0929867003375281","volume":"7","author":"D Bai","year":"2000","unstructured":"Bai D, Tang X, He X (2000) Huperzine A, a potential therapeutic agent for treatment of Alzheimer\u2019s disease. Curr Med Chem 7:355\u2013374","journal-title":"Curr Med Chem"},{"key":"5258_CR244","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/aps.2012.128","volume":"33","author":"H-y Zhang","year":"2012","unstructured":"Zhang H-y (2012) New insights into huperzine A for the treatment of Alzheimer\u2019s disease. Acta Pharmacol Sin 33:1170\u20131175","journal-title":"Acta Pharmacol Sin"},{"key":"5258_CR245","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/cbdv.201000269","volume":"8","author":"GT Ha","year":"2011","unstructured":"Ha GT, Wong RK, Zhang Y (2011) Huperzine a as potential treatment of Alzheimer\u2019s disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodivers 8:1189\u20131204","journal-title":"Chem Biodivers"},{"key":"5258_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-021-05762-x","volume":"14","author":"HJ Jafaar","year":"2021","unstructured":"Jafaar HJ, Isbilen O, Volkan E, Sariyar G (2021) Alkaloid profiling and antimicrobial activities of Papaver glaucum and P. decaisnei. BMC Res Notes 14:1\u20137","journal-title":"BMC Res Notes"},{"key":"5258_CR247","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/rej.2013.1473","volume":"17","author":"L Elyasi","year":"2014","unstructured":"Elyasi L, Eftekhar-Vaghefi SH, Esmaeili-Mahani S (2014) Morphine protects SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine\u2013induced cell damage: involvement of anti-oxidant, calcium blocking, and anti-apoptotic properties. Rejuvenation Res 17:255\u2013263","journal-title":"Rejuvenation Res"},{"key":"5258_CR248","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1080\/01480545.2021.1957558","volume":"45","author":"D Cans\u0131z","year":"2022","unstructured":"Cans\u0131z D, Ustundag UV, Unal I, Alturfan AA, Emekli-Alturfan E (2022) Morphine attenuates neurotoxic effects of MPTP in zebrafish embryos by regulating oxidant\/antioxidant balance and acetylcholinesterase activity. Drug Chem Toxicol 45:2439\u20132447","journal-title":"Drug Chem Toxicol"},{"key":"5258_CR249","doi-asserted-by":"publisher","first-page":"16227","DOI":"10.1523\/JNEUROSCI.3915-11.2011","volume":"31","author":"J Cui","year":"2011","unstructured":"Cui J, Wang Y, Dong Q, Wu S, Xiao X, Hu J, Chai Z, Zhang Y (2011) Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. J Neurosci 31:16227\u201316240","journal-title":"J Neurosci"},{"key":"5258_CR250","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s11481-011-9337-9","volume":"7","author":"S-L Chen","year":"2012","unstructured":"Chen S-L, Tao P-L, Chu C-H, Chen S-H, Wu H-E, Tseng LF, Hong J-S, Lu R-B (2012) Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol 7:444\u2013453","journal-title":"J Neuroimmune Pharmacol"},{"key":"5258_CR251","doi-asserted-by":"publisher","first-page":"63","DOI":"10.12659\/MSMBR.890557","volume":"20","author":"C Snyder","year":"2014","unstructured":"Snyder C, Mantione K (2014) The effects of morphine on Parkinson\u2019s-related genes PINK1 and PARK2. Med Sci Monit Basic Res 20:63","journal-title":"Med Sci Monit Basic Res"},{"key":"5258_CR252","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10792-022-02424-0","volume":"43","author":"M Cevik","year":"2023","unstructured":"Cevik M, Gobeka HH, Aydemir O (2023) Effects of neferine on retinal tissue in experimental diabetic rat model. Int Ophthalmol 43:249\u2013260","journal-title":"Int Ophthalmol"},{"key":"5258_CR253","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/pm.pm_291_19","volume":"17","author":"S Jing","year":"2021","unstructured":"Jing S, Wang Z, Zhang J, Li X, Huang R (2021) Neuroprotective effect of neferine, an alkaloid against the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced Parkinson\u2019s disease mouse model. Phcog Mag 17:186","journal-title":"Phcog Mag"},{"key":"5258_CR254","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.3390\/molecules20033496","volume":"20","author":"VKW Wong","year":"2015","unstructured":"Wong VKW, Wu AG, Wang JR, Liu L, Law BY-K (2015) Neferine attenuates the protein level and toxicity of mutant huntingtin in PC-12 cells via induction of autophagy. Molecules 20:3496\u20133514","journal-title":"Molecules"},{"key":"5258_CR255","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/pharmaceutics13040581","volume":"13","author":"MA Abourehab","year":"2021","unstructured":"Abourehab MA, Khames A, Genedy S, Mostafa S, Khaleel MA, Omar MM, El Sisi AM (2021) Sesame oil-based nanostructured lipid carriers of nicergoline, intranasal delivery system for brain targeting of synergistic cerebrovascular protection. Pharmaceutics 13:581","journal-title":"Pharmaceutics"},{"key":"5258_CR256","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2165\/00044011-200121090-00004","volume":"21","author":"B Winblad","year":"2001","unstructured":"Winblad B, Bonura ML, Rossini BM, Battaglia A (2001) Nicergoline in the treatment of mild-to-moderate Alzheimer\u2019s disease: a European multicentre trial. Clin Drug Investig 21:621\u2013632","journal-title":"Clin Drug Investig"},{"key":"5258_CR257","doi-asserted-by":"publisher","first-page":"104","DOI":"10.12779\/dnd.2017.16.4.104","volume":"16","author":"JJ Im","year":"2017","unstructured":"Im JJ, Jeong HS, Park J-S, Yang Y, Na S-H, Oh JK, Chung Y-A, Song I-U (2017) Changes in regional cerebral perfusion after nicergoline treatment in early Alzheimer\u2019s disease: a pilot study. Dementia Neurocogn Disord 16:104","journal-title":"Dementia Neurocogn Disord"},{"key":"5258_CR258","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ima.22320","volume":"29","author":"JJ Im","year":"2019","unstructured":"Im JJ, Jeong H, Oh JK, Chung YA, Song IU, Lee KS (2019) Effects of nicergoline treatment on regional cerebral blood flow in early Alzheimer\u2019s disease. Int J Imaging Syst Technol 29:323\u2013328","journal-title":"Int J Imaging Syst Technol"},{"key":"5258_CR259","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jocn.2019.08.048","volume":"70","author":"S Lee","year":"2019","unstructured":"Lee S, Na S-H, Chung Y-A, Jeong H, Song I-U (2019) Efficacy of nicergoline treatment in Parkinson\u2019s disease associated with dementia. J Clin Neurosci 70:136\u2013139","journal-title":"J Clin Neurosci"},{"key":"5258_CR260","doi-asserted-by":"crossref","unstructured":"Tarabasz D, Kukula\u2010Koch W. Palmatine: a review of pharmacological properties and pharmacokinetics. Phytotherapy Research. 2020 Jan;34(1):33-50.","DOI":"10.1002\/ptr.6504"},{"key":"5258_CR261","doi-asserted-by":"publisher","first-page":"9966223","DOI":"10.1155\/2021\/9966223","volume":"2021","author":"W Jia","year":"2021","unstructured":"Jia W, Su Q, Cheng Q, Peng Q, Qiao A, Luo X, Zhang J, Wang Y (2021) Neuroprotective effects of palmatine via the enhancement of antioxidant defense and small heat shock protein expression in A\u03b2-transgenic Caenorhabditis elegans. Oxidative Med Cell Longevity 2021:9966223","journal-title":"Oxidative Med Cell Longevity"},{"key":"5258_CR262","doi-asserted-by":"publisher","first-page":"54","DOI":"10.14715\/cmb\/2020.66.4.9","volume":"66","author":"SKM Chaves","year":"2020","unstructured":"Chaves SKM, Afzal MI, Islam MT, Hameed A, Da Mata AMOF, da Silva AL, Ali SW, Rolim HML, De Medeiros MdGF, Costa EV (2020) Palmatine antioxidant and anti-acetylcholinesterase activities: a pre-clinical assessment. Cell Mol Biol (Noisy-le-grand) 66:54\u201359","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"5258_CR263","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23200","volume":"36","author":"H Pei","year":"2022","unstructured":"Pei H, Zeng J, Chen W, He Z, Du R (2022) Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer\u2019s disease. J Biochem Mol Toxicol 36:e23200","journal-title":"J Biochem Mol Toxicol"},{"key":"5258_CR264","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/pharmaceutics13081170","volume":"13","author":"RG Geetha","year":"2021","unstructured":"Geetha RG, Ramachandran S (2021) Recent advances in the anti-inflammatory activity of plant-derived alkaloid rhynchophylline in neurological and cardiovascular diseases. Pharmaceutics 13:1170","journal-title":"Pharmaceutics"},{"key":"5258_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113568","volume":"268","author":"M Zheng","year":"2021","unstructured":"Zheng M, Chen M, Wang W, Zhou M, Liu C, Fan Y, Shi D (2021) Protection by rhynchophylline against MPTP\/MPP+-induced neurotoxicity via regulating PI3K\/Akt pathway. J Ethnopharmacol 268:113568","journal-title":"J Ethnopharmacol"},{"key":"5258_CR266","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11064-015-1730-y","volume":"40","author":"H Shao","year":"2015","unstructured":"Shao H, Mi Z, Ji W-g, Zhang C-h, Zhang T, S-c R, Zhu Z-r (2015) Rhynchophylline protects against the amyloid \u03b2-induced increase of spontaneous discharges in the hippocampal CA1 region of rats. Neurochem Res 40:2365\u20132373","journal-title":"Neurochem Res"},{"key":"5258_CR267","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2147\/IJN.S236922","volume":"15","author":"R Xu","year":"2020","unstructured":"Xu R, Wang J, Xu J, Song X, Huang H, Feng Y, Fu C (2020) Rhynchophylline loaded-mPEG-PLGA nanoparticles coated with tween-80 for preliminary study in Alzheimer\u2019s disease. Int J Nanomed 15:1149\u20131160","journal-title":"Int J Nanomed"},{"key":"5258_CR268","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2018.03.007","volume":"135","author":"Y Yang","year":"2018","unstructured":"Yang Y, Ji W-g, Zhu Z-r, Wu Y-l, Z-y Z, Qu S-c (2018) Rhynchophylline suppresses soluble A\u03b21-42-induced impairment of spatial cognition function via inhibiting excessive activation of extrasynaptic NR2B-containing NMDA receptors. Neuropharmacology 135:100\u2013112","journal-title":"Neuropharmacology"},{"key":"5258_CR269","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1039\/D2FO02939A","volume":"14","author":"C Zhang","year":"2023","unstructured":"Zhang C, Xue Z, Zhu L, Zhou J, Zhuo L, Zhang J, Zhang X, Liu W, Han L, Liao W (2023) Rhynchophylline alleviates neuroinflammation and regulates metabolic disorders in a mouse model of Parkinson\u2019s disease. Food Funct 14:3208\u20133219","journal-title":"Food Funct"},{"key":"5258_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.113065","volume":"222","author":"H Lin","year":"2023","unstructured":"Lin H, Xie L, Lv L, Chen J, Feng F, Liu W, Han L, Liu F (2023) Intranasally administered thermosensitive gel for brain-targeted delivery of rhynchophylline to treat Parkinson\u2019s disease. Colloids Surf B 222:113065","journal-title":"Colloids Surf B"},{"key":"5258_CR271","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.joim.2021.01.001","volume":"19","author":"EWC Chan","year":"2021","unstructured":"Chan EWC, Wong SK, Chan HT (2021) An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. J Integr Med 19:311\u2013316","journal-title":"J Integr Med"},{"key":"5258_CR272","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s11064-022-03553-9","volume":"47","author":"H Liu","year":"2022","unstructured":"Liu H, He S, Wang J, Li C, Liao Y, Zou Q, Chen R (2022) Tetrandrine ameliorates traumatic brain injury by regulating autophagy to reduce ferroptosis. Neurochem Res 47:1574\u20131587","journal-title":"Neurochem Res"},{"key":"5258_CR273","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/08923973.2021.1979036","volume":"43","author":"C Li","year":"2021","unstructured":"Li C, Chai A, Gao Y, Qi X, Zheng X (2021) Combination of tetrandrine and 3-n-butylphthalide protects against cerebral ischemia-reperfusion injury via ATF2\/TLR4 pathway. Immunopharmacol Immunotoxicol 43:749\u2013757","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5258_CR274","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.intimp.2011.03.023","volume":"11","author":"FQ He","year":"2011","unstructured":"He FQ, Qiu BY, Li TK, Xie Q, Cui DJ, Huang XL, Gan HT (2011) Tetrandrine suppresses amyloid-\u03b2-induced inflammatory cytokines by inhibiting NF-\u03baB pathway in murine BV2 microglial cells. Int Immunopharmacol 11:1220\u20131225","journal-title":"Int Immunopharmacol"},{"key":"5258_CR275","doi-asserted-by":"publisher","first-page":"454","DOI":"10.4103\/1673-5374.179058","volume":"11","author":"Y-l Lv","year":"2016","unstructured":"Lv Y-l, Wu Z-z, Chen L-x, Wu B-x, Chen L-l, Qin G-c, Gui B, Zhou J-y (2016) Neuroprotective effects of tetrandrine against vascular dementia. Neural Regen Res 11:454\u2013459","journal-title":"Neural Regen Res"},{"key":"5258_CR276","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-022-00871-6","volume":"29","author":"BC-K Tong","year":"2022","unstructured":"Tong BC-K, Huang AS, Wu AJ, Iyaswamy A, Ho OK-Y, Kong AH-Y, Sreenivasmurthy SG, Zhu Z, Su C, Liu J (2022) Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies. J Biomed Sci 29:85","journal-title":"J Biomed Sci"},{"key":"5258_CR277","first-page":"9966223","volume":"2015","author":"X-Y Li","year":"2015","unstructured":"Li X-Y, Mei G-H, Dong Q, Zhang Y, Guo Z-L, Su J-J, Tang Y-P, Jin X-H, Zhou H-G, Huang Y-Y (2015) Enhanced neuroprotective effects of coadministration of tetrandrine with glutathione in preclinical model of Parkinson\u2019s disease. Parkinson\u2019s Dis 2015:9966223","journal-title":"Parkinson\u2019s Dis"},{"key":"5258_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129142","volume":"1225","author":"AFF L\u00f3pez","year":"2021","unstructured":"L\u00f3pez AFF, Mart\u00ednez OMM, Hern\u00e1ndez HFC (2021) Evaluation of Amaryllidaceae alkaloids as inhibitors of human acetylcholinesterase by QSAR analysis and molecular docking. J Mol Struct 1225:129142","journal-title":"J Mol Struct"},{"key":"5258_CR279","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1460-9568.2009.06612.x","volume":"29","author":"JB Melo","year":"2009","unstructured":"Melo JB, Sousa C, Gar\u00e7\u00e3o P, Oliveira CR, Agostinho P (2009) Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Eur J Neurosci 29:455\u2013464","journal-title":"Eur J Neurosci"},{"key":"5258_CR280","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001747.pub3","author":"C Loy","year":"2006","unstructured":"Loy C, Schneider L (2006) Galantamine for Alzheimer\u2019s disease and mild cognitive impairment. Cochrane Database of Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001747.pub3","journal-title":"Cochrane Database of Syst Rev"},{"key":"5258_CR281","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/gps.409","volume":"16","author":"Wilkinson D, Murray Ji and Group GR","year":"2001","unstructured":"Wilkinson D, Murray Ji and Group GR (2001) Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry 16:852\u2013857","journal-title":"Int J Geriatr Psychiatry"},{"key":"5258_CR282","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1586\/14737175.8.1.9","volume":"8","author":"G Razay","year":"2008","unstructured":"Razay G, Wilcock GK (2008) Galantamine in Alzheimer\u2019s disease. Expert Rev Neurother 8:9\u201317","journal-title":"Expert Rev Neurother"},{"key":"5258_CR283","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jnnp.71.5.589","volume":"71","author":"K Rockwood","year":"2001","unstructured":"Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D (2001) Effects of a flexible galantamine dose in Alzheimer\u2019s disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatry 71:589\u2013595","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5258_CR284","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1176\/appi.ajp.161.3.532","volume":"161","author":"JL Cummings","year":"2004","unstructured":"Cummings JL, Schneider L, Tariot PN, Kershaw PR, Yuan W (2004) Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer\u2019s disease. Am J Psychiatry 161:532\u2013538","journal-title":"Am J Psychiatry"},{"key":"5258_CR285","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/gps.949","volume":"18","author":"D Aarsland","year":"2003","unstructured":"Aarsland D, Hutchinson M, Larsen J (2003) Cognitive, psychiatric and motor response to galantamine in Parkinson\u2019s disease with dementia. Int J Geriatr Psychiatry 18:937\u2013941","journal-title":"Int J Geriatr Psychiatry"},{"key":"5258_CR286","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00702-014-1358-0","volume":"122","author":"D Jiang","year":"2015","unstructured":"Jiang D, Yang X, Li M, Wang Y, Wang Y (2015) Efficacy and safety of galantamine treatment for patients with Alzheimer\u2019s disease: a meta-analysis of randomized controlled trials. J Neural Transm 122:1157\u20131166","journal-title":"J Neural Transm"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05258-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:20:27Z","timestamp":1757161227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05258-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":286,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5258"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05258-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the author(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}